Chrysanthemum Zawadskii Var. and Platycodon Grandifloras Extract Mixture Protects Against Lipopolysaccharide-Induced Pulmonary Inflammation and Cyclophosphamide-Induced Immune Deficiency: In Vivo Evidence
Journal of Medicinal Food · 2025
DOI: 10.1089/jmf.2024.k.0245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Food, 2025. Verfasst von Dong-Uk Jo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science & Biotechnology, Sejong University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Platycodon, Plant Extracts, Chrysanthemum, Pneumonia. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Respiratory tract diseases (RTDs) cause airflow limitations and impaired respiratory function, primarily due to pulmonary inflammation and immune dysfunction. Chrysanthemum zawadskii var. latilobum Kitamur and Platycodon grandifloras (CP) are traditional herbs known for their anti-inflammatory and immune-enhancing properties. This study investigates the anti-inflammatory and immune-enhancing effects of a combined extract of CP in vivo. CP was prepared by mixing equal volumes of Chrysanthemum zawadskii extract (CE) and Platycodon grandifloras extract (PE) at the same concentration. The anti-inflammatory effects of CP were evaluated using a lipopolysaccharide (LPS)-induced inflammation model in BALB/c mice. The immune-enhancing effects were assessed using a cyclophosphamide (CYP)-induced immunosuppression model. Protein and mRNA expressions of inflammatory and immune markers were analyzed through Western blotting and quantitative real-time PCR. CP significantly reduced LPS-induced pulmonary inflammation by decreasing interleukin (IL)-1β and cyclooxygenase-2 expression in lung tissues. In the CYP-induced model, CP treatment restored spleen and thymus weights, reversed reductions in immune cell counts, and increased TNF-α and IL-2 mRNA expression in the spleen. In conclusion, CP inhibits pulmonary inflammation by suppressing inflammatory mediators and enhances immune function by increasing immune-related indicators. This suggests that CP may have potential therapeutic applications for treating respiratory inflammation and related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science & Biotechnology, Sejong University, Seoul, Republic of Korea.
- Division of Functional Food Research, Korea Food Research Institute, Wanju-gun, Republic of Korea.
- Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA.
- Department of Food Science & Biotechnology, and Carbohydrate Bioproduct Research Center, Sejong University, Seoul, Republic of Korea.
ORCID-Profile: Tae-Gyu Lim
Zitieren
APA
Jo, D. U., Kim, Y., Ko, H., Hong, S., Lim, W., & Lim, T. G. (2025). Chrysanthemum Zawadskii Var. and Platycodon Grandifloras Extract Mixture Protects Against Lipopolysaccharide-Induced Pulmonary Inflammation and Cyclophosphamide-Induced Immune Deficiency: In Vivo Evidence. Journal of Medicinal Food. https://doi.org/10.1089/jmf.2024.k.0245
Vancouver
Jo DU, Kim Y, Ko H, Hong S, Lim W, Lim TG. Chrysanthemum Zawadskii Var. and Platycodon Grandifloras Extract Mixture Protects Against Lipopolysaccharide-Induced Pulmonary Inflammation and Cyclophosphamide-Induced Immune Deficiency: In Vivo Evidence. Journal of Medicinal Food. 2025. doi:10.1089/jmf.2024.k.0245
BibTeX
@article{Jo2025,
author = {Jo, Dong-Uk and Kim, Yongeun and Ko, Heejin and Hong, Sujung and Lim, Wonchul and Lim, Tae-Gyu},
title = {Chrysanthemum Zawadskii Var. and Platycodon Grandifloras Extract Mixture Protects Against Lipopolysaccharide-Induced Pulmonary Inflammation and Cyclophosphamide-Induced Immune Deficiency: In Vivo Evidence},
journal = {Journal of Medicinal Food},
year = {2025},
doi = {10.1089/jmf.2024.k.0245}
}
EUVIMED